Alan B. Lancz & Associates, Inc. Roche Hldg LTD Spons Adr Transaction History

Alan B. Lancz & Associates, Inc.

  • $108 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$39.15 - $43.25 $301,455 - $333,025
7,700 New
7,700 $301,000
Q2 2022

Aug 11, 2022
SELL
$38.21 - $53.44 $297,312 - $415,816
-7,781 Closed
0 $0
Q4 2021

Apr 13, 2022
SELL
$46.65 - $52.3 $4.01 Million - $4.5 Million
-86,000 Reduced 91.7%
7,781 $402,000
Q4 2021

Feb 09, 2022
BUY
$46.65 - $52.3 $4.37 Million - $4.9 Million
93,781 New
93,781 $4.85 Million

Others Institutions Holding RHHBY

# of Institutions
79
Shares Held
8.47M
Call Options Held
0
Put Options Held
0
View Full List

About ROCHE HLDG LTD SPONS ADR

RHHBY Quotes by TradingView
  • Ticker RHHBY
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 6,404,630,016
  • Market Cap $225B
More about RHHBY
Track This Portfolio

Track Alan B. Lancz & Associates, Inc. Portfolio

Follow Alan B. Lancz & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alan B. Lancz & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Alan B. Lancz & Associates, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email